GBS/CIDP Foundation Company Profile

12:12 EST 16th December 2018 | BioPortfolio

GBS is an inflammatory disorder of the peripheral nerves and is characterized by the rapid onset of weakness and often paralysis of the legs, arms, breathing muscles and face. GBS can develop in persons of any age. CIDP is a rare disorder of the peripheral nerves with weakness occurring over two or more months and is characterized by gradually increasing weakness of the legs and, to a lesser extent, the arms. It is caused by damage to the covering of the nerves called myelin.

News Articles [419 Associated News Articles listed on BioPortfolio]

Is it Guillain-Barré or Acute-onset CIDP?

Acute inflammatory demyelinating polyneuropathy and acute-onset chronic inflammatory demyelinating polyneuropathy (CIDP) may present with identical clinical pictures and can be differentiated only wit...

[Comment] Fingolimod and CIDP: insights from negative results

Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is an immune-mediated neuropathy that is frequently responsive to treatment with intravenous immunoglobulin (IVIg) or corticosteroids, ...

Steroid Treatment Regimens for Chronic Inflammatory Demyelinating Polyneuropathy

In the United States, first-line treatment for chronic inflammatory demyelinating polyneuropathy (CIDP) is intravenous immunoglobulin (IVIG). Authors of this retrospective survey from Europe found tha...

Treatment Options for CIDP

What is known about chronic inflammatory demyelinating polyradiculoneuropathy, a neurological disorder marked by by progressive weakness and impaired sensory function in the extremeties?

The Ewing Marion Kauffman Foundation: Entrepreneurship and Success

In this interview, Lesa Mitchell, VP Kauffman Foundation, Ewing Marion Kauffman Foundation, talks to Dr Fintan Walton about: • the Foundation’s origins and its focus on entrepreneurship • its re...

Chronic Inflammatory Demyelinating Polyneuropathy CIDP Pipeline Review, H2 2018 [Report Updated: 14082018] Prices from USD $2000

Chronic Inflammatory Demyelinating Polyneuropathy CIDP Pipeline Review, H2 2018SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chronic Inflammatory Demyelin...

Kessler Foundation receives grant to study outcomes of new stroke treatment

(Kessler Foundation) Kessler Foundation has been awarded a $50,000 grant by the Charles and Ann Serraino Foundation, Inc.

[Articles] Oral fingolimod for chronic inflammatory demyelinating polyradiculoneuropathy (FORCIDP Trial): a double-blind, multicentre, randomised controlled trial

Fingolimod 0·5 mg once-daily was not better than placebo for the treatment of CIDP. Future trial designs should take account of the possibility that if IVIg is stopped abruptly, some patients might r...

Drugs and Medications [451 Associated Drugs and Medications listed on BioPortfolio]

Esika [Ventura Corporation (San Juan, P.R)]

ēsika 3-in-1 Pro Make Up Foundation SPF 20

Sheer cover mineral foundation [Guthy-Renker LLC]

Sheer Cover Mineral Foundation SPF-15

Cle de peau beaute silky foundation i [SHISEIDO CO., LTD.]

CPB Silky Cream Foundation I

Cle de peau beaute foundation i [SHISEIDO CO., LTD.]

cle de peau BEAUTE Cream Foundation I

Shiseido perfect refining foundation [SHISEIDO AMERICA INC.]

SHISEIDO Perfect Refining Foundation

PubMed Articles [214 Associated PubMed Articles listed on BioPortfolio]

The economic burden of CIDP in the United States: A case-control study.

Chronic inflammatory demyelinating polyneuropathy (CIDP) is a rare neurological disorder of the peripheral nervous system. The economic burden of CIDP is not well understood.

Presence of both anti-contactin 1 and anti-neurofascin 140 antibodies in a case of chronic inflammatory demyelinating polyneuropathy.

Chronic inflammatory demyelinating polyneuropathy (CIDP) is an acquired disorder of peripheral nerves and nerve roots. Its cause is unknown, but recently antibodies to nodal and paranodal proteins hav...

Nerve ultrasound can distinguish chronic inflammatory demyelinating polyneuropathy from demyelinating diabetic sensorimotor polyneuropathy.

Diabetic patients with poor glycaemic control can demonstrate demyelinating distal sensorimotor polyneuropathy (D-DSP) on electrophysiology. Distinguishing D-DSP from chronic inflammatory demyelinatin...

Chronic inflammatory demyelinating polyneuropathy: considerations for diagnosis, management, and population health.

First described almost 50 years ago, chronic inflammatory demyelinating polyneuropathy (CIDP) is a rare autoimmune disorder characterized by progressive peripheral neuropathy. CIDP is difficult to dia...

Short-term and long-term effects of immunoadsorption in refractory chronic inflammatory demyelinating polyneuropathy: a prospective study in 17 patients.

Chronic inflammatory demyelinating polyneuropathy (CIDP) is a rare, autoimmune-inflammatory disease of the peripheral nervous system. Recently, various immunoglobulin G4 (IgG4) type auto-antibodies ha...

Clinical Trials [284 Associated Clinical Trials listed on BioPortfolio]

Single vs. Multiple Privigen Dose Regimens in Pediatric CIDP

A randomized, open‑label, prospective, multicenter study designed to investigate 2 dose regimens in pediatric subjects 2 to < 17 years of age with confirmed or possible CIDP, either prev...

Biomark Study: Predict Intravenous Immunoglobulin Responders in Chronic Inflammatory Demyelinating Polyradiculoneuropathy

This study aims analyze the transcriptome to identify predictive biomarkers of IVIG in CIDP patients. 25 patients with a diagnosis of CIDP according to European criteria, naïve of treatme...

Panzyga in CIDP Administered at Different Infusion Rates

Chronic inflammatory demyelinating polyneuropathy (CIDP) is a treatable form of peripheral neuropathy with suspected autoimmune cause. The current first-line treatment is IVIG (immune glob...

Diffusion Tensor Imaging in Chronic Inflammatory Demyelinating Polyneuropathy (PIDC)

The main purpose of this study is to assess the clinical feasibility of diffusion tensor imaging (DTI) for the diagnosis of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)...

Long-Term Tolerability and Safety of HYQVIA/HyQvia in CIDP

The purpose of this study is to assess the long-term safety, tolerability, and immunogenicity of the subcutaneous (SC) treatment with Immune Globulin Subcutaneous (IGSC) facilitated with r...

Companies [1386 Associated Companies listed on BioPortfolio]

The GBS/CIDP Foundation International

GBS/CIDP Foundation

GBS is an inflammatory disorder of the peripheral nerves and is characterized by the rapid onset of weakness and often paralysis of the legs, arms, breathing muscles and face. GBS can develop in pers...

AVA Foundation

The AVA Foundation is a 501(c)(3) educational and research foundation dedicated to saving lives through promoting risk-free vascular access and evidence-based clinical practice. T...

COSHAR Foundation

The COSHAR Foundation is a 501( c )3 organization dedicated to "Impacting the Health of the World, One Community at a Time." The COSHAR Foundation's NHMN includes more than 14,000 churches and 220 co...

The NASCAR Foundation

The National Association for Stock Car Auto Racing, Inc., (NASCAR) launched The NASCAR Foundation in January 2006. The Foundation is a 501(c)(3) non-profit entity that embodies the compassion of the N...

More Information about "GBS/CIDP Foundation" on BioPortfolio

We have published hundreds of GBS/CIDP Foundation news stories on BioPortfolio along with dozens of GBS/CIDP Foundation Clinical Trials and PubMed Articles about GBS/CIDP Foundation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of GBS/CIDP Foundation Companies in our database. You can also find out about relevant GBS/CIDP Foundation Drugs and Medications on this site too.

Quick Search


Relevant Topic

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...

Corporate Database Quicklinks

Searches Linking to this Company Record